Namouni Fouad

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
7
Insider Sells Sum
$1.6M

Insider Activity of Namouni Fouad

According to the SEC Form 4 filings, Namouni Fouad, being in a position of

  1. PRESIDENT, R & D at Blueprint Medicines Corporation,
    оver the last 12 months, has bought 0 shares, and sold 8010 shares for $721,450,
    over all time since 2021-10-05, has bought 0 shares, and sold 21492 shares for $1.6M.

The largest sale of all time was on 2024-03-07 and amounted to 4377 shares of Blueprint Medicines Corporation for $396,950.

Biography of Namouni Fouad

No biography is available at this moment.

2024-10-03SaleBlueprint Medicines Corporation
BPMC
PRESIDENT, R & D
3,633
0.0058%
$89.32$324,500+6.59%
2024-03-07SaleBlueprint Medicines Corporation
BPMC
PRESIDENT, R & D
4,377
0.007%
$90.69$396,950+1.64%
2023-10-04SaleBlueprint Medicines Corporation
BPMC
PRESIDENT, R & D
3,769
0.0061%
$48.06$181,138+93.89%
2023-03-06SaleBlueprint Medicines Corporation
BPMC
1,948
0.0034%
$45.68$88,977+32.68%
2022-10-04SaleBlueprint Medicines Corporation
BPMC
PRESIDENT, R & D
3,477
0.0059%
$67.30$234,002
2022-03-07SaleBlueprint Medicines Corporation
BPMC
PRESIDENT, R & D
1,047
0.0018%
$56.19$58,831-0.54%
2021-10-05SaleBlueprint Medicines Corporation
BPMC
President, R & D
3,241
0.0056%
$98.18$318,201-29.08%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.